<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>About Elanco App</title>
   <link rel="stylesheet" href="about.css">
</head>

<body>

    <header>
        <h1>About Elanco App</h1>
    </header>

    <main>
        <section>
            <h2>Mission Statement</h2>
            <p>Elanco is committed to using its animal health expertise to build a sustainable, healthier world for
                animals and people.</p>
        </section>

        <section>
            <h2>Company History</h2>
            <ul>
                <li><strong>1954:</strong> In 1953, Lilly launched the first antibiotic for exclusive veterinary use. In
                    1954, the company formally organized its plant and animal science activities into the Agricultural
                    and Industrial Sales Division, led by George Varnes. The Elanco brand, short for Eli Lilly and
                    Company, came to be in 1960, following the reorganization of Eli Lilly and Company's Agricultural
                    and Industrial Sales Division.</li>

                <li><strong>1960:</strong> The Elanco brand was established following the reorganization of Eli Lilly
                    and Company's Agricultural and Industrial Sales Division.</li>

                <li><strong>2007:</strong> Elanco acquired Ivy Animal Health, a leader in the development, registration,
                    and marketing of animal health products in Canada.</li>

                <li><strong>2015:</strong> Elanco acquired Novartis Animal Health, expanding its companion animal
                    portfolio and global reach.</li>

                <li><strong>2018:</strong> Elanco became a publicly traded company on the New York Stock Exchange.</li>

                <li><strong>2020:</strong> Elanco acquired Bayer Animal Health, creating the second-largest animal
                    health company by revenue. The acquisition expanded Elanco's portfolio and capabilities, positioning
                    the company for long-term growth.</li>

                <li><strong>2021:</strong> In August 2021, Elanco announced it had closed its acquisition of Kindred
                    Biosciences, enhancing its existing biologics and monoclonal antibody pipeline. The business plans
                    to break ground on the new headquarters in the first half of 2021.</li>

                <li><strong>2022:</strong> Elanco's Healthy Purpose, Elanco, and the diagonal bar logo are trademarks of
                    Elanco or its affiliates.</li>
            </ul>
        </section>

        <section class="tools-section">
            <h2>About Elanco Apps</h2>
            <p>Elanco Apps is a platform designed to display a data resource group, application name/service name, and
                various tools related to trend analysis.</p>
            <p>The application provides a comprehensive dashboard where users can visualize trends related to resource
                groups and application names or service names.</p>
            <p>Additionally, Elanco Apps includes a dedicated section called the "Tools Dashboard" that offers tools for
                advanced analysis and insights.</p>
        </section>

    </main>

    <footer>
        <p>&copy; 2024 Elanco Apps. All rights reserved.</p>
    </footer>

</body>

</html>